BD Alaris™ Pump Module infusion sets designed for the BD Alaris™ Pump Module.
BD Alaris™ Pump Module infusion sets designed for the BD Alaris™ Pump Module.
GTIN - Case
50885403271029
20
GTIN - each
10885403271021
1
Natural Latex
Yes
CE Marking
No
Case Dimensions
11.438in x 7in x 9.5in
Approximate Length
321 cm
Approximate Length
126 in
Approximate Priming Volume
26 mL
Clamp
Pinch, roller
Color of Tubing
None
Drop
20
Filter
None
Luer Lock Type
Texium™ closed male luer
Manifold
None
Number of Backcheck Valves
1
Number of Connectors
1
Number of Fuses
0
Number of Y-Sites
3
Sterility
Fluid path sterile
Stopcock
None
T-Connector Type
None
Type of Connector
Texium™
Y-Site Port Type
SmartSite™
GTIN - Case | 50885403271029 | 20 |
GTIN - each | 10885403271021 | 1 |
Natural Latex | Yes |
CE Marking | No |
Case Dimensions | 11.438in x 7in x 9.5in |
Approximate Length | 321 cm |
Approximate Length | 126 in |
Approximate Priming Volume | 26 mL |
Clamp | Pinch, roller |
Color of Tubing | None |
Drop | 20 |
Filter | None |
Luer Lock Type | Texium™ closed male luer |
Manifold | None |
Number of Backcheck Valves | 1 |
Number of Connectors | 1 |
Number of Fuses | 0 |
Number of Y-Sites | 3 |
Sterility | Fluid path sterile |
Stopcock | None |
T-Connector Type | None |
Type of Connector | Texium™ |
Y-Site Port Type | SmartSite™ |
BD offers training resources to help improve your clinical practices as part of our goal of advancing the world of health.
BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.
BD promotes clinical excellence by providing various resources on best practices, clinical innovations and industry trends in healthcare.
If you are a patient or end user, you can contact us yourself, or you may have your caregiver or your physician do that for you. To help us process your
information quickly and effectively, please contact our customer complaints
team.
To better facilitate our investigation, please include the following information in your reporting: